Method of forming an MT-propyl siloxane resin
US-9221848-B2 · Dec 29, 2015 · US
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8962029B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962029-B2 |
| Application number | US-201314015015-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 30, 2013 |
| Priority date | May 27, 2005 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
First claim
Opening claim text (preview).
That which is claimed: 1. A nitric oxide-releasing particle comprising: a co-condensed silica network comprising aminoethylaminopropyl trimethoxysilane (AEAP3) and tetraethyl orthosilicate (TEOS), wherein the AEAP3 is distributed throughout the nitric oxide-releasing particle, and wherein the AEAP3 comprises N-diazeniumdiolate functionalized AEAP3. 2. The nitric oxide-releasing particle of claim 1 , wherein the AEAP3 is present in a mol % of 1% to 90%.…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8962029B2 cover?
- The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications.
- Who is the assignee on this patent?
- Univ North Carolina
- What technology area does this patent fall under?
- Primary CPC classification C07F7/10. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).